Apmonia therapeutics is a startup based in France, most recent round Series A, 2 tracked investors.
Based in France, Apmonia therapeutics is a startup founded in 2019. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Apmonia Therapeutics is a biotech company developing therapeutic strategies for multiple types of cancer, focusing on next-generation peptide-based therapies targeting the tumor microenvironment to improve patient outcomes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.